All in all, since the FOMC raised rates in December, the US economy had been growing at a relatively modest pace.
Sentiment started to improve with the publication of more encouraging data later in the month. Retail sales surged +1.3% m-o-m in April and the preliminary results from the University of Michigan’s consumer sentiment survey for May also showed notably more optimism.
The Minutes of April’s FOMC meeting pointed to a stronger economy and read more hawkish than anticipated by most investors. On 29 May, Janet Yellen stated that the ongoing improvement in the US economy would warrant another interest-rate increase “in the coming months".
At sector level, the energy sector, which had been nicely rebounding, suffered some profit-taking despite an ongoing recovery in oil prices. On the other hand, investors were seen chasing some tech, with Apple rebounding on bargain-hunting. During this risk-on move, investors preferred to buy growth stocks rather than value stocks.
- We have reduced positions in Industrials and Materials and reinvested the proceeds mainly in Healthcare and IT.
- We raised or initiated positions in, among others, Apple, Amgen, NXPI, Amazon and Johnson&Johnson, while reducing or selling positions in, for instance, Fedex, Occidental Petroleum and EOG Resources.
- Currently, the most important sectors in our strategy are Consumer Discretionary, Consumer Staples, Healthcare, Industrials and IT.
- Our largest active positions are Medtronic, Pepsico, Time Warner, Nike, Accenture and Johnson&Johnson.
- The IMF expected world economic growth forecast of around 3.2% in 2016 and 3.5% in 2017 seems very challenging in the current environment.
- However, as we currently observe some early macroeconomic improvement in the US and even in Emerging Markets, we think that our portfolio should be gradually reoriented towards more cyclical sectors.
- The low interest-rate environment, reasonably priced equity markets, high free-cash generation, increasing dividends and stock buy-backs, M&A activity and decent Q1 results still warrant a cautiously optimistic scenario for the equity markets.

Monthly Strategic Insight
Read moreEquities
News